Medi-Moses showcases 30 years of turning plant medicine research into products
A Ghanaian herbal medicine company, Medi-Moses Group of Companies, says its nearly three decades of work in research and development demonstrate that locally generated scientific discoveries can be transformed into medicines that benefit patients. The company, led by medical doctor and pharmacognosist Dr De-Gaulle Moses Dogbatsey, says its work aligns with calls by Health Minister […]
Ghanaian herbal medicine company Medi-Moses Group of Companies has been turning plant medicine research into products for nearly 30 years, according to a recent report. Led by medical doctor and pharmacognosist Dr De-Gaulle Moses Dogbatsey, the company's work aligns with Health Minister Kwabena Mintah Akandoh's call for Ghanaian researchers to move their discoveries from laboratories into commercially viable medicines and vaccines.
Akandoh recently underscored the importance of government support for research beyond funding, emphasizing the need for research projects to become commercially viable products. Ghana must focus on local pharmaceutical production to reduce dependence on imported medicines and vaccines, retain foreign exchange, create jobs, and improve preparedness for future health emergencies.
Medi-Moses' experience demonstrates how research into medicinal plants can be translated into patient-friendly products. Dr Dogbatsey, who holds an MPhil in Pharmacognosy from Kwame Nkrumah University of Science and Technology (KNUST), has formulated 57 herbal products targeting various health conditions, including enlarged prostate and prostatitis.
The company's products have been endorsed by the Society of Private Medical and Dental Practitioners for their contribution to patient care.
Written by urgent.news from Adom Online's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
